IgG4-related disease in a Chinese cohort: A prospective study

Scandinavian Journal of Rheumatology

Volumn 43, Issue 1, 2014, Pages 70-74

  Chen, H ^a   Lin, W ^a   Wang, Q ^a   Wu, Q ^a   Wang, L ^a   Fei, Y ^a   Zheng, W ^a   Fei, G ^a   Li, P ^a   Li, Y Z ^a   Zhang, W ^a   Zhao, Y ^a   Zeng, X ^a   Zhang, F ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN SUBCLASS; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ABDOMINAL PAIN; ADULT; ALLERGIC DISEASE; AORTA DISEASE; ARTHRALGIA; ARTICLE; AUTOIMMUNE PANCREATITIS; CELL INFILTRATION; CHINESE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; COUGHING; DISEASE DURATION; DYSURIA; EDEMA; EOSINOPHILIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FIBROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOGLOBULIN G4 RELATED DISEASE; INTERSTITIAL NEPHRITIS; INTERSTITIAL PNEUMONIA; JAUNDICE; LABORATORY TEST; LACRIMAL GLAND DISEASE; LACRIMATION; LOW BACK PAIN; LYMPHADENOPATHY; LYMPHOCYTE; MALE; MEDICAL HISTORY; MIDDLE AGED; NAUSEA AND VOMITING; PAROTID GLAND DISEASE; PLASMA CELL GRANULOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATITIS; PRURITUS; RETROPERITONEAL FIBROSIS; SALIVARY GLAND DISEASE; SALIVATION; SCLEROSING CHOLANGITIS; SIALOADENITIS; SINUSITIS; SYMPTOM; YOUNG ADULT;

ADULT; AGED; AUTOIMMUNE DISEASES; CHINA; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREDNISONE; PROSPECTIVE STUDIES;

EID: 84892985684     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.822094     Document Type: Article

References (20)

1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl JMed 2012;366:539-51.
2. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8. (Pubitemid 32204991)
3. Bourlon MT, Chapa M, Chable Montero F, Hernandez Calleros J. Immunoglobulin G4-associated to multiorganic lymphoproliferative disease [in Spanish]. Gac Med Mex 2011;147:545-50.
4. Ebbo M, Daniel L, Pavic M, Sève P, Hamidou M, Andres E, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry.Medicine (Baltimore) 2012;91:49-56.
5. Hsu B-B, Lai N-S, Tung C-H. Clinical images: lacrimal gland and renal involvement in IgG4-related sclerosing disease. Arthritis Rheum 2011;63:3875.
6. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:982-4. (Pubitemid 37455786)
7. Raina A, Yadav D, Krasinskas AM, McGrath KM, Khalid A, Sanders M, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009;104:2295-306.
8. Watanabe T, Maruyama M, Ito T, Fujinaga Y, Ozaki Y, Kodama R, et al. Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol. Published online: 16 March 2013. doi:10.3109/03009742.2012.761281.
9. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012;22:21-30.
10. Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, et al. Proposal for a new clinical entity, IgG4- positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009;68:1310-15.
11. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 2012;22:1-14.
12. van der Vliet HJJ, Perenboom RM. Multiple pseudotumors in IgG4- associated multifocal systemic fibrosis. Ann Int Med 2004;141: 896-7. (Pubitemid 39601195)
13. Sato Y, Kojima M, Takata K, Morito T, Asaoku H, Takeuchi T, et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol 2009;22:589-99.
14. Kamisawa T, AnjikiH, Egawa N, Kubota N. Allergic manifestations in autoimmune pancreatitis.Eur JGastroenterol Hepatol 2009;21:1136-9.
15. Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538-46. (Pubitemid 46918338)
16. Nakatani K, Nakamoto Y, Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol 2012;67:297-305.
17. CarruthersMN,Stone JH,Deshpande V, KhosroshahiA.Development of an IgG4-RD responder index. Int J Rheumatol 2012; Article ID 259408.
18. Moon SH, KimMH, ParkDH, Hwang CY, Park SJ, Lee SS, et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008;57:1704-12.
19. Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol 2012; Article ID 580814.
20. Terzin V, Foldesi I, Kovacs L, Pokorny G, Wittmann T, Czako L. Association between autoimmune pancreatitis and systemic autoimmune diseases. World J Gastroenterol 2012;18:2649-53.